Conversations on 
Twitter :
 |
|
|
|
@FierceBiotech: Eli Lilly hits the brakes on PhIII program in arthritis after 'unexpected' results. Story | Follow @FierceBiotech
@JohnCFierce: Who releases PhIII results one endpoint at a time? Stock up, but $ONCY PR is weak, manipulative. Count me skeptical. More | Follow @JohnCFierce
@RyanFierce: AZN missed big in Phase IIb for oral arthritis drug after previous mixed results. Should have killed program earlier? Report | Follow @RyanMFierce
> GlaxoSmithKline ($GSK), Sanofi ($SNY) and others from the pharma world have turned to traditional Chinese remedies for new potential drugs. Article
> Add another deal to the growing list of tie-ups between pharma outfits and academics. Eisai has struck an R&D alliance with University College London focused on therapies for Alzheimer's and other neurological diseases. Report
> Synta Pharmaceuticals ($SNTA), a developer of drugs against cancer and inflammation, has raised $60 million in a sale of common stock to its board members and institutional investors. Release
> The FDA accepted a New Drug Application for Lundbeck and Takeda's antidepressant. Item
> The contract research outfit Huntingdon Life Sciences could ax up to 100 jobs, blaming weak demand for outsourcing from pharma companies. Report
Pharma News
@FiercePharma: KV says it's set to emerge from bankruptcy. News | Follow @FiercePharma
> Pfizer to pay $55 million to clean Wyeth's dirty laundry. Item
> AstraZeneca, Lilly feeling real pain in race for arthritis drugs. News
> FDA risk finding adds fuel to fire around Pfizer's Chantix. Story
@FierceMedDev: AspenBio Pharma seeks rebirth as Venaxis, with focus on diagnostics. More | Follow @FierceMedDev
@MarkHFierce: A conservative Washington Post blogger calls out medical device tax "hypocrites" who voted for it and now oppose it. Story | Follow @MarkHFierce
@DamianFierce: Between FDA earfuls, analyst warnings and, now, a shareholder lawsuit, St. Jude Medical is having a rough winter. Article | Follow @DamianFierce
> Covidien gets Canadian nod for stroke-treating Solitaire. News
> Biocartis bags $44.5M Series D for molecular Dx commercialization. More
> St. Jude faces shareholder suit over Durata claims. Report
Vaccine News
> GSK employs mobile phones to up vaccination rates in Africa. Report
> TB vaccine tested in infants of HIV-positive mothers. News
> IDRI fetches $10M from Gates Foundation for adjuvant research. Story
> GAVI Alliance aims to immunize 30 million girls against HPV. Item
> Global pediatric vaccine market to hit $23B by 2015. Article
Pharma Manufacturing News
> Court OKs drug-shortage lawsuit against Hospira. News
> Manufacturing at the heart of Teva's $2B cost-cutting drive. Story
> 6 hospitalized as Novartis manufacturing stumbles again. Article
And Finally… Since investigators began a hunt for Pfizer's missing gold dust, industry watchers have been speculating on what the drug giant ($PFE) was doing with all the precious metal in the first place. Blog